Dmitry Balyasny’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$452K Buy
40,853
+10,035
+33% +$61.4K ﹤0.01% 2565
2026
Q1
$236K Buy
30,818
+5,499
+22% +$42K ﹤0.01% 2644
2025
Q4
$246K Sell
25,319
-2,602,781
-99% -$22.1M ﹤0.01% 2815
2025
Q3
$11M Buy
2,628,100
+2,195,448
+507% +$14M 0.01% 1002
2025
Q2
$4.02M Buy
432,652
+99,415
+30% +$867K 0.01% 1389
2025
Q1
$3.25M Buy
+333,237
New +$4.12M 0.01% 1464

Other funds holding REPL

Dmitry Balyasny's REPL Position: Q2 2026 in Review

Dmitry Balyasny increased its Replimune Group (REPL) stake by 33% in Q2 2026, buying an estimated $61.4K and bringing the position to 40,853 shares worth $452K. The position accounts for ﹤0.01% of the portfolio, ranked #2565.

Dmitry Balyasny first reported a position in REPL in Q1 2025 and has held it in 6 quarters since. The position peaked at $11M in Q3 2025. 198 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Dmitry Balyasny held 40,853 shares of Replimune Group worth $452K as of Q2 2026.
  • Dmitry Balyasny bought 10,035 Replimune Group shares in Q2 2026, an estimated $61.4K.
  • Replimune Group made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2565 holding.
  • Dmitry Balyasny first reported a position in Replimune Group in Q1 2025 and has held it in 6 quarters since.
  • Dmitry Balyasny's Replimune Group position peaked at $11M in Q3 2025.
  • 198 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.